News

All current DZIF news can be found here.

A lab technician at a sterile bench and two others standing in the background, all wearing lab coats, gloves and sterile head covers. The person at the bench is holding a tube in the hand, visible on the bench is a stand with many tubes with black screw caps.

A new dawn in the fight against Tuberculosis

Today, UNITE4TB, an international public-private partnership striving to fast-track the development of innovative tuberculosis (TB) treatments, announced the start of its phase-IIb/c-clinical trial

DZIF Executive Board member Prof. Maura Dandri, DZIF managing director Dr Timo Jäger and ANRS | MIE Director Prof. Yazdan Yazdanpanah at the signing ceremony of the MoU at ANRS | MIE in Paris. Standing in the background are Roll-ups of ANRS | MIE and DZIF.

Collaboration of the DZIF and the French ANRS | MIE to advance research in infectious diseases

The German Center for Infection Research (DZIF) and the French National Research Agency for HIV, viral hepatitis and emerging infectious diseases (ANRS | MIE) announced their commitment to

A female doctor wearing a white coat injects the upper arm of an elderly man.

Protection against respiratory diseases: Medical associations recommend new RSV vaccination

New protection against severe respiratory diseases: Experts from eleven medical societies and institutions—including researchers from the German Center for Infection Research—are now calling on people

Cryo-electron microscopic reconstruction of molecular structures: On the left, the vertical representation of the binding of a yellow-coloured antibody to the blue-coloured tip of the secretion system shown in grey. On the right, a top view of the binding structure, showing how the yellow antibody binds laterally to the blue tip of the secretion system, which is round in top view.

Neutralising antibodies that target resistant bacteria

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared

An Indian female lab technician holds the test cartridge tested in the study in her right hand.

New tool makes it easier to diagnose tuberculosis in children

Around 240,000 children worldwide die of tuberculosis every year. The disease is among the top ten causes of death in children under the age of five. One of the main reasons for this mortality is that

Whitish Acinetobacter baumannii colonies on a red agar plate

Avoiding the further spread of carbapenem-resistant Acinetobacter baumannii

Researchers from the German Center for Infection Research (DZIF) at the University of Cologne have conducted a study on the carbapenem-resistant bacterium Acinetobacter baumannii. The pathogen was

A photo of the podium - part of the audience can be seen from behind. Joël Denis stands at the lectern, the presentation slides are shown on a large screen.

How to create incentives for the development of novel antibiotics?

Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new

The award winner Ralf Bartenschlager stands in the middle of the picture, to his right is Nadja Käding from the DZIF Academy, and to the left of Prof. Bartenschlager is DZIF Chairman Prof. Dirk Busch.

Virologist Ralf Bartenschlager honoured with the DZIF Prize for Translational Infection Research

The German Center for Infection Research (DZIF) honours the virologist Prof. Dr Dr h. c. Ralf Bartenschlager from the Heidelberg University Hospital. The DZIF Prize for Translational Infection

Portrait of Dr. Janko Sattler. Mr Sattler is wearing a dark suit and tie.

Research award for DZIF Scientist Janko Sattler

DZIF scientist Dr Janko Sattler, a medical specialist at the Institute for Medical Microbiology, Immunology and Hygiene at the University Hospital Cologne, was awarded the bioMérieux Diagnostics Prize

Successfully promoting new approaches to antibacterial therapies: INCATE celebrates its two-year anniversary

The INCubator for Antibacterial Therapies in Europe, INCATE, can point to an impressive series of successes on its two-year anniversary. With direct contact to more than 180 start-ups and initiatives